Fidelity International reduced its holdings of Joinn Laboratories (06127) by 1.6108 million shares, with an average price of approximately HKD 21.57 per share.
On September 16th, Fidelity International reduced its holding of China Medical System (06127) by 1.6108 million shares, with an average price per share of HK$21.5742, totaling approximately HK$34.7517 million.
According to the latest data from the Hong Kong Stock Exchange, on September 16, Fidelity International reduced its holdings of Joinn Laboratories (06127) by 1.6108 million shares, with an average price of 21.5742 Hong Kong dollars per share, totaling approximately 34.7517 million Hong Kong dollars. The latest number of shares held after the reduction is 11.4548 million shares, with a latest shareholding percentage of 9.63%.
This transaction involves other related parties: Pandanus Associates Inc., Pandanus Partners L.P.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
